CAN-FITE BIOPHARMA LTD. Inactive Instrument
Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE
Equities
CANF
IL0010944739
Pharmaceuticals
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Planet MicroCap Showcase
| 1st Jan change | Capi. | |
|---|---|---|
| -2.86% | 87.31B | |
| +3.95% | 40.86B | |
| -21.94% | 29.36B | |
| +56.34% | 24.49B | |
| -5.41% | 17.31B | |
| -44.23% | 11.26B | |
| -17.60% | 11.62B | |
| -13.96% | 11.31B | |
| +6.44% | 8.31B |
